Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast
The use of a hand-held positron emission tomography (PET) probe during breast surgery can potentially reduce the rate of second operations, having a number of implications. The PET probe tested in ductal carcinoma in situ (DCIS) surgery demonstrated to be 96.5% accurate when compared to pathology. T...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
Curtin University
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/2414 |
| _version_ | 1848743947879317504 |
|---|---|
| author | Butler-Henderson, Kerryn Ann |
| author_facet | Butler-Henderson, Kerryn Ann |
| author_sort | Butler-Henderson, Kerryn Ann |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | The use of a hand-held positron emission tomography (PET) probe during breast surgery can potentially reduce the rate of second operations, having a number of implications. The PET probe tested in ductal carcinoma in situ (DCIS) surgery demonstrated to be 96.5% accurate when compared to pathology. This research examines the current technology available, the epidemiology of DCIS in Western Australia, testing of the radiopharmaceutical used with the probe and the PET probe itself. |
| first_indexed | 2025-11-14T05:53:40Z |
| format | Thesis |
| id | curtin-20.500.11937-2414 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T05:53:40Z |
| publishDate | 2014 |
| publisher | Curtin University |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-24142017-02-20T06:38:10Z Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast Butler-Henderson, Kerryn Ann The use of a hand-held positron emission tomography (PET) probe during breast surgery can potentially reduce the rate of second operations, having a number of implications. The PET probe tested in ductal carcinoma in situ (DCIS) surgery demonstrated to be 96.5% accurate when compared to pathology. This research examines the current technology available, the epidemiology of DCIS in Western Australia, testing of the radiopharmaceutical used with the probe and the PET probe itself. 2014 Thesis http://hdl.handle.net/20.500.11937/2414 en Curtin University fulltext |
| spellingShingle | Butler-Henderson, Kerryn Ann Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast |
| title | Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast |
| title_full | Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast |
| title_fullStr | Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast |
| title_full_unstemmed | Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast |
| title_short | Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast |
| title_sort | radiopharmaceuticals and the pet probe in the detection of ductal carcinoma in situ of the breast |
| url | http://hdl.handle.net/20.500.11937/2414 |